Private Equity
Search documents
X @Bloomberg
Bloomberg· 2025-07-22 13:24
Investment Opportunity - Private equity firms struggling to realize returns may offer opportunities for distressed debt investors [1] Industry Analysis - Glendon Capital co-founder Holly Kim highlights the potential for distressed debt investors [1]
KKR首支在岸人民币基金落地上海:超4亿元!
Sou Hu Cai Jing· 2025-07-22 00:50
文:韦亚军 新加坡曹宝记(TPC)集团通过在华平台曹宝记(中国)企业管理有限公司出资0.6亿元,占14.63%, 为第二大LP。 施罗德资本则通过旗下海南三亚施罗德股权投资基金合伙企业(有限合伙)出资0.23亿元,占5.58%,为第三大LP。 通过出资结构,我们可以看出这是典型的"外资GP+境内机构LP"组合。 在过去的2年里,放眼中国一级市场,除了KKR,其他几乎能够叫得出名字的全球PE巨头,包括华平投资、汉领资本(Hamilton Lane)、路威凯腾(L Catterton)、施罗德资本、亚赋资本(Affirma Capital)、博枫(Brookfield)、以及黑石、凯雷、CVC等,都已经募集过或正在募集人民币基金。 摄影:Bob君 募集人民币基金,已经成为跨国PE们的新共识。 近日,KKR境内管理实体开德时璞(上海)私募投资基金合伙企业(有限合伙)在中国证券投资基金业协会完成备案,基金类型为私募股权基金。这标 志着KKR首支在岸人民币基金正式落地。 开德时璞成立于2024年12月,注册地在上海浦东,由KKR香港公司100%控股。 其中,平安资本通过旗下母基平台——金嘉兴平汇利海股权投资合伙企业(有 ...
X @Bloomberg
Bloomberg· 2025-07-21 17:12
Investment & Funding - L Catterton 领投 Flexjet 8 亿美元的股权投资 [1] Industry Trend - 全球对私人飞机旅行的需求持续激增 [1]
Lantheus Holdings: Forget The Short Term Noise
Seeking Alpha· 2025-07-21 12:57
Core Insights - Lantheus (NASDAQ: LNTH) stock experienced a significant decline from $108 to $80 between January and May 2025, indicating volatility in its performance [1] Company Overview - MMMT Wealth, founded by Oliver, focuses on investment strategies and stock analysis, primarily in private equity, hedge funds, and asset management [1] - Oliver has 5 years of investing experience and 4 years as a CPA, emphasizing a long-term investment horizon of 3-5 years [1] Investment Philosophy - The company aims to gather insights from various sources, including investor calls, presentations, and financial reports, to form informed opinions on stocks [1] - Oliver's passion for investing is highlighted, with a belief that even a few successful investments can be life-changing [1]
X @Bloomberg
Bloomberg· 2025-07-19 13:06
Transaction Overview - CVC Capital Partners initiates refinancing of its sports assets portfolio [1] - The portfolio is valued at over £9 billion, equivalent to $12 billion [1]
Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company's Board of Directors
Globenewswire· 2025-07-17 12:15
Core Insights - Royalty Pharma plc has appointed Carole Ho and Elizabeth (Bess) Weatherman to its Board of Directors, enhancing its leadership team with expertise in biopharmaceuticals and finance [1][2][3] Group 1: Board Appointments - Carole Ho is the Chief Medical Officer and Head of Development at Denali Therapeutics, with 20 years of experience in biopharma, previously serving as Vice President of Clinical Development at Genentech [2][3] - Bess Weatherman has 35 years of experience as an investor in the healthcare industry and is currently a Special Limited Partner at Warburg Pincus, having joined the firm in 1988 [3] Group 2: Company Overview - Royalty Pharma, founded in 1996, is the largest buyer of biopharmaceutical royalties and a key funder of innovation in the biopharmaceutical sector, collaborating with various innovators [4] - The company has a portfolio that includes royalties on over 35 commercial products and 16 development-stage product candidates, indicating a strong position in the market [4] Group 3: Corporate Governance - The appointment of the new board members increases independent representation on the board to over 90%, reflecting Royalty Pharma's commitment to enhanced corporate governance [5]
基金退出业绩线上分享会即将启动
FOFWEEKLY· 2025-07-17 10:01
Group 1 - The core viewpoint of the article highlights a structural recovery in the primary market driven by policy incentives and market vitality since 2025, with a notable increase in merger and acquisition transactions and a surge in Hong Kong IPOs in the first half of the year, providing new exit channels [1] - The fundraising data is also showing a rebound trend, although Limited Partners (LPs) are raising their expectations regarding General Partners (GPs) in terms of project control, performance certainty, and clarity of exit paths [1][4] - FOFWEEKLY has compiled a report titled "Fund Exit and Performance Benchmark Research," which systematically reviews the evolution of exit methods and analyzes the changing demands and preferences of LPs based on in-depth industry observations [1][4] Group 2 - The research discusses the changes in the scale and methods of exits for Private Equity (PE) and Venture Capital (VC) funds in recent years, breaking down performance metrics of hundreds of PE and VC funds across various dimensions such as year, scale, and industry to form industry benchmarks [4] - The online event will focus on the current state of the primary market and case studies, as well as the changes and challenges faced by state-owned LPs and financial LPs, along with their evolving demands [5][9]
X @Bloomberg
Bloomberg· 2025-07-17 05:50
Swedish private equity group EQT reports better-than-expected underlying profit in the first half of 2025 as exit volumes jumped and all of its funds performed at or above plan https://t.co/VLI9ZAX3AJ ...
创投圈开始流行写小说
3 6 Ke· 2025-07-17 03:31
Core Viewpoint - The investment and venture capital industry is experiencing a significant transformation, marked by a rise in social media narratives reflecting the challenges faced by professionals, while simultaneously, there are signs of recovery in policies and market data [1][9][22]. Group 1: Industry Sentiment and Trends - There is a growing trend of "sad literature" on social media, where industry professionals share their experiences and challenges through humorous and fictional narratives [3][5]. - The number of active voices on social media from industry practitioners has increased, indicating a shift in how professionals are engaging with the market [7][13]. - The sentiment among smaller General Partners (GPs) is one of low confidence and emotional fatigue, with many reporting a lack of investment activity over the past year [6][9]. Group 2: Market Recovery Signals - Recent data shows a significant increase in the number of Chinese companies going public, with 109 listings in the first half of 2025, a 32.9% year-on-year increase [10]. - The decision-making efficiency of Limited Partners (LPs) has improved, with a noticeable uptick in investment confidence and activity among state-owned funds [11]. - The emergence of "patient capital" is becoming a focal point in the industry, with many funds extending their investment horizons to 15-20 years, allowing for more strategic investments [12]. Group 3: Opportunities in the Market - There are opportunities in underdeveloped regions, as local GPs may lack the capacity to effectively utilize government funds, creating a gap that can be exploited by more capable firms [17]. - The current environment allows for the conversion of social media engagement into resource leverage, providing a dual benefit of income and resource attraction for industry professionals [18][19]. - The investment landscape is being shaped by favorable policies and technological advancements, creating a strategic opportunity for players in the market [21].
X @The Wall Street Journal
The Wall Street Journal· 2025-07-16 20:33
Speed-dating-style interviews that can drag on until 3 a.m. Job offers that require a response within a day. All for positions that don’t even start for two to three years.Welcome to the frenzied world of private-equity recruiting.Read more: https://t.co/jgE9DW3IU2 https://t.co/CTjnx7PuOL ...